» Authors » Martin Proescholdt

Martin Proescholdt

Explore the profile of Martin Proescholdt including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 96
Citations 1946
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Brandl B, Steiger M, Kubelt C, Rohrandt C, Zhu Z, Evers M, et al.
Nat Med . 2025 Feb; PMID: 40021833
Although the intraoperative molecular diagnosis of the approximately 100 known brain tumor entities described to date has been a goal of neuropathology for the past decade, achieving this within a...
2.
Irmer B, Wlochowitz D, Krekeler C, Richter K, Chandrabalan S, Bayerlova M, et al.
Mol Oncol . 2025 Jan; 19(3):614-634. PMID: 39825568
The transcriptomic classification of primary colorectal cancer (CRC) into distinct consensus molecular subtypes (CMSs) is a well-described strategy for patient stratification. However, the molecular nature of CRC metastases remains poorly...
3.
Araceli T, Fischl A, Haj A, Doenitz C, Stoerr E, Hillberg A, et al.
Front Oncol . 2024 Dec; 14:1463467. PMID: 39669367
Purpose: The development of brain metastases (BM) can significantly increase the psycho-oncological burden in cancer patients, requiring timely intervention. In addition, this aspect may negatively affect the course of the...
4.
Wasilewski D, Araceli T, Bischoff P, Fruh A, Ates R, Murad S, et al.
J Neurooncol . 2024 Dec; 171(3):637-649. PMID: 39630375
Background: Thyroid Transcription Factor-1 (TTF-1) expression in lung adenocarcinoma (LUAD) has been studied for its prognostic value in early-stage and metastatic disease. Its role in brain metastasis remains unexplored. This...
5.
Gotz L, Ansafi T, Gerken M, Klinkhammer-Schalke M, Fischl A, Riemenschneider M, et al.
Neurooncol Adv . 2024 Nov; 6(1):vdae170. PMID: 39493414
Background: Glioblastoma (GB) is the most frequent malignant brain tumor and has a dismal prognosis. In other cancers, antibiotic use has been associated with severity of chemotherapy-induced toxicity and outcome....
6.
Fischl A, Gerken M, Lindberg-Scharf P, Haedenkamp T, Rosengarth K, Hillberg A, et al.
Curr Oncol . 2024 Oct; 31(10):6155-6170. PMID: 39451763
(1) Background: Clinical aspects like sex, age, Karnofsky Performance Scale (KPS) and psychosocial distress can affect the health-related quality of life (HR-QoL) and treatment satisfaction of patients with malignant isocitrate...
7.
Salvotti H, Lein A, Proescholdt M, Schmidt N, Siller S
Curr Oncol . 2024 Jul; 31(7):4079-4092. PMID: 39057176
Objective: Intradural spinal metastases are considered rare. At present, limited information is available on incidence, surgical management, and outcomes. Methods: We conducted a retrospective patient chart review from 2002 to...
8.
Schuster M, Braun F, Chiang D, Ludwig C, Meng C, Gratz C, et al.
Front Immunol . 2024 May; 15:1388769. PMID: 38726003
Background: Newer 3D culturing approaches are a promising way to better mimic the tumor microenvironment and to study the interactions between the heterogeneous cell populations of glioblastoma multiforme. Like many...
9.
Brundl E, Proescholdt M, Schodel P, Rosengarth K, Storr E, Bele S, et al.
Front Neurol . 2024 Mar; 14:1325950. PMID: 38425753
Background: The vaso- and psychoactive endogenous Neuropeptide Y (NPY) has repeatedly been shown to be excessively released after subarachnoid hemorrhage and in numerous psychiatric disorders. NPY is stored in sympathetic...
10.
Mirian C, Rehne Jensen L, Juratli T, Maier A, Torp S, Shih H, et al.
J Neurooncol . 2024 Feb; 166(3):503-511. PMID: 38336917
Background: The risk of recurrence is overestimated by the Kaplan-Meier method when competing events, such as death without recurrence, are present. Such overestimation can be avoided by using the Aalen-Johansen...